Glevate Dosage & Drug Information

Concise Prescribing Info

Contents

Clobetasol propionate

Indications/Uses

Short-term treatment of dermatoses eg, psoriasis (excluding widespread plaque psoriasis), recalcitrant eczema, lichen planus, discoid lupus erythematosus & other skin conditions which do not respond to less active corticosteroids.

Dosage/Direction for Use

Apply sparingly to affected area once-bid. Max dose & duration: 50 g/wk for 2 wk.

Contraindications

Rosacea, acne, perioral dermatitis, primary cutaneous viral (herpes simplex, chickenpox), fungal (candidiasis, tinea) & bacterial infections. Childn <12 yr. Pregnancy.

Special Precautions

Systemic absorption results in reversible hypothalamic pituitary adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia & glucosuria. Avoid contact w/ the eyes. Do not cover treated skin area.

Adverse Reactions

Localized burning & stinging sensation. Itching, skin atrophy, cracking & fissuring of the skin. Folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, allergic contact & perioral dermatitis, maceration of the skin, secondary infection, striae & miliaria.

View ADR Monitoring Form

MIMS Class

Topical Corticosteroids

ATC Classification

D07AD01 - clobetasol ; Belongs to the class of very potent (group IV) corticosteroids. Used in the treatment of dermatological diseases.

Regulatory Classification

Presentation/Packing

Form

Glevate cream 0.05 % w/w

Packing/Price

15 g x 1's (P492/tube);5 g x 1's (P224.2/tube)

Glevate

clobetasol

Manufacturer:

Glenmark

Distributor:

Metro Drug